Fruquintinib Clinical Trials
27 recruitingDrug
Phase 219Not Applicable3Phase 42Phase 32Phase 12
Showing 1–20 of 27 trials
Recruiting
Not Applicable
Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)Antineoplastic Agents, ImmunologicalVEGFR-TKI
Federation Francophone de Cancerologie Digestive300 enrolled83 locationsNCT07124858
Recruiting
Phase 2
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Colorectal, Cancer
Kahr Bio Australia Pty Ltd90 enrolled17 locationsNCT07235293
Recruiting
Phase 4
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Colorectal, Cancer
Takeda78 enrolled45 locationsNCT06562543
Recruiting
Phase 2
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Colorectal, CancerMinimal Residual DiseasectDNA+3 more
M.D. Anderson Cancer Center20 enrolled1 locationNCT07136077
Recruiting
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled1 locationNCT06417892
Recruiting
Phase 3
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Colorectal, Cancer
Chipscreen Biosciences, Ltd.430 enrolled1 locationNCT06497985
Recruiting
Phase 2
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Colorectal, Cancer
Criterium, Inc.120 enrolled9 locationsNCT06992258
Recruiting
Phase 2
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
Gastric Cancer Adenocarcinoma Metastatic
Dai, Guanghai68 enrolled1 locationNCT07392346
Recruiting
Phase 1Phase 2
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Advanced Solid Tumors
AskGene Pharma, Inc.594 enrolled4 locationsNCT05867420
Recruiting
Phase 2
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
Colorectal, Cancer
Fudan University50 enrolled2 locationsNCT05954429
Recruiting
Phase 2
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest140 enrolled23 locationsNCT06856837
Recruiting
Phase 2
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Barbara Ann Karmanos Cancer Institute102 enrolled9 locationsNCT07130903
Recruiting
Phase 2Phase 3
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
Colorectal, Cancer
Sun Yat-sen University84 enrolled1 locationNCT06441565
Recruiting
Phase 2
Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
Colorectal, CancerMicrosatellite Stable Colorectal Carcinoma
Fudan University25 enrolled1 locationNCT05771181
Recruiting
Phase 1
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Colon CancerMetastatic Colon Cancer
Sapience Therapeutics130 enrolled11 locationsNCT05848739
Recruiting
Phase 2
Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
Gastric Cancer
First Affiliated Hospital of Fujian Medical University40 enrolled1 locationNCT06791083
Recruiting
Phase 2
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
FruquintinibS-1Raltitrexed
Meng Qiu66 enrolled2 locationsNCT06427005
Recruiting
Phase 2
A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG
Gastric/Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital69 enrolled1 locationNCT06774222
Recruiting
Phase 2
Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
Hepatocellular CarcinomaImmune Checkpoint InhibitorsSecond-line Treatment+1 more
Sun Yat-sen University36 enrolled1 locationNCT06446154
Recruiting
Phase 2
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Dai, Guanghai46 enrolled1 locationNCT06685276